中藥緩解修格蘭氏症合併橋本氏甲狀腺炎之病例報告

Chinese Herbal Medicine for Alleviating the Patient with Sjögren's Syndrome Combined with Hashimoto's Thyroiditis: A Case Report

10.6516/TJTCM.202012_23(3).0011

陳國豐(Kuo-Feng Chen)；曾偉婷(Wei-Ting Tseng)；林虹均(Hong-Chun Lin)；張清貿(Ching-Mao Chang)

修格蘭氏症候群 ； 橋本氏甲狀腺炎 ； 滋陰降火 ； 清熱利溼 ； Sjögren's Syndrome ； Hashimoto's Thyroiditis ； Nourish Yin to Extinguish Fire ； Clean Heat and Eliminate Dampness

中醫藥研究論叢

23卷3期（2020 / 12 / 30）

141 - 150

繁體中文

一名患有修格蘭氏症候群（Sjögren's syndrome）合併橋本氏甲狀腺炎（Hashimoto's thyroiditis）的55歲女性，主要症狀有心悸、喘、水腫、指麻、口乾舌燥、手腳指頭麻、雙腳起紅疹，該患者於2019年08月23日至臺北榮民總醫院傳統醫學部門診就診，中醫辨證為陰虛內熱、溼熱下注、肝腎陰虛，治則為滋陰降火、清熱利溼、滋補肝腎。持續追蹤治療7次後，有效改善心悸、喘、小腿水腫、潮熱、盜汗等症狀。本病例報告顯示合併中藥治療可有效緩解修格蘭氏症候群合併橋本氏甲狀腺炎患者之複雜症狀，可提供中藥輔助治療之參考。

A 55-year-old female woman diagnosed as Sjögren's syndrome with Hashimoto's thyroiditis. She visited Center for Traditional Medicine of Taipei Veterans General Hospital on August 23, 2019, and her main symptoms were palpitations, wheezing, calf edema, numb fingers, and rash on both feet. Due to the pattern of ＂Yin Deficiency and Internal Heat＂, ＂Downward Diffusion of Damp-Heat＂, ＂Liver and Kidney Yin Deficiency＂, the TCM doctor adopted ＂Nourish yin to extinguish fire＂, ＂Clean heat and eliminate dampness＂ plus ＂Nourish Liver and Kidney＂ to treat her. After seven continuous follow-up treatments, the symptoms were effectively improved. This case report showed that the collaboration between Chinese herbal medicine and conventional medicine could effectively alleviate the complex symptoms of patients with Sjögren's syndrome combined with Hashimoto's thyroiditis. Moreover, Chinese herbal medicine treatment could be a complementary therapy for conventional medicine.

1. Ajjan, RA,Weetman, AP(2015).The Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in our Understanding.Horm Metab Res,47,702-710.
2. Anaya, JM,Restrepo-Jimenez, P,Rodriguez, Y,Rodriguez-Jimenez, M,Acosta-Ampudia, Y,Monsalve, DM,Pacheco, Y,Ramirez-Santana, C,Molano-Gonzalez, N,Mantilla, RD(2019).Sjogren’s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin.Clin Rev Allergy Immunol,56,362-374.
3. Caturegli, P,De Remigis, A,Rose, NR(2014).Hashimoto thyroiditis: clinical and diagnostic criteria.Autoimmun Rev,13,391-397.
4. Effraimidis, G(2019).MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in autoimmune thyroid disease: are they useful?.Eur J Endocrinol,181,R119-R131.
5. Flynn, RW,MacDonald, TM,Morris, AD,Jung, RT,Leese, GP(2004).The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population.J Clin Endocrinol Metab,2004(89),3879-3884.
6. Hu, S,Rayman, MP(2017).Multiple Nutritional Factors and the Risk of Hashimoto’s Thyroiditis.Thyroid,27,597-610.
7. Leese, GP,Flynn, RV,Jung, RT,Macdonald, TM,Murphy, MJ,Morris, AD(2008).Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS).Clin Endocrinol,2008(68),311-316.
8. McLeod, DS,Cooper, DS(2012).The incidence and prevalence of thyroid autoimmunity.Endocrine,2012(42),252-265.
9. Mori, K,Nakagawa, Y,Ozaki, H(2012).Does the gut microbiota trigger Hashimoto's thyroiditis?.Discov Med,2012(14),321-326.
10. Poplawska-Kita, A,Telejko, B,Siewko, K,Kosciuszko-Zdrodowska, M,Wawrusewicz-Kurylonek, N,Kretowski, A,Hryniewicka, J,Dzieciol, J,Bauer, W,Milewski, R,Szelachowska, M,Gorska, M(2014).Decreased Expression of Thyroglobulin and Sodium Iodide Symporter Genes in Hashimoto’s Thyroiditis.Int J Endocrinol,2014,690704.
11. Ragusa, F,Fallahi, P,Elia, G,Gonnella, D,Paparo, SR,Giusti, C,Churilov, LP,Ferrari, SM,Antonelli, A(2019).Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy.Best Pract Res Clin Endocrinol Metab,2019(33),101367.
12. Stafford, EA,Rose, NR(2000).Newer insights into the pathogenesis of experimental autoimmune thyroiditis.Int Rev Immunol,19,501-533.
13. 王福凱,馬雙雙,梁棟(2018)。橋本氏甲狀腺炎病因病機與中醫命名思考。時珍國醫國藥雜誌，12，2998-3000。
14. 王濟玉,謝勤(2017)。疏肝健脾方治療橋本氏甲狀腺炎合併甲狀腺功能減退療效觀察。山西中醫雜誌，11，28-29。
15. 付佳聞,沈遠東,陸灝(2016)。橋本氏甲狀腺炎的中醫研究進展。上海中醫藥大學學報，3，102-106。
16. 李堂(2012)。橋本甲狀腺炎的發病機制與診治進展。實用兒科臨床雜誌，8，563-565。
17. 迪娜 ‧ 塔吾列,溫偉波(2019)。橋本甲狀腺炎的中醫研究進展。雲南中醫中藥雜誌，5，78-80。
18. 高青,簡立信,許金國,李文林,簡志偉,潘蘇華(2012)。橋本甲狀腺炎病因病機與臨床治療研究進展。中國中藥雜誌，20，3003-3006。
19. 張毅,張敏,黃寧靜(2014)。外用青黛治療橋本甲狀腺炎療效及其對甲狀腺自身免疫性抗體的影響。中國中醫藥信息雜誌，21，24-26。
20. 馮靜,周志剛,鄭寒丹,周建華,崔云華,劉雅楠,趙繼夢,李中秋,馬喆(2019)。近十年中醫藥治療橋本甲狀腺炎概況與思考。江西中醫藥雜誌，5，70-74。
21. 楊菲,許進,張雪珂,楊迎軍(2014)。夏枯草膠囊治療單純甲狀腺自身抗體異常的橋本甲狀腺炎療效觀察。河北中醫雜誌，11，1693-1694。
22. 趙江,劉維(2019)。橋本甲狀腺炎中醫藥治療研究進展。遼寧中醫藥大學學報，2，151-154。
23. 黎建華,譚海燈(2017)。中醫經方分期論治聯合西藥治療橋本氏甲狀腺炎的臨床研究。深圳中西醫結合雜誌，3，24-25。
24. 韓靜,劉守堯(2019)。橋本氏甲狀腺炎中西醫治療研究進展。中華中醫藥雜誌，11，5327-5330。
25. 黨羽,梁棟(2016)。橋本甲狀腺炎中西醫病因病機研究概況。醫學綜述，2，322-325。

1. 謝懷棣,謝孟蓁,楊政議,彭芷瑜,留美萍,李麗紅,李品萱(2023)。修格蘭氏症候群病人之求醫經驗。護理雜誌，70(5)，36-43。